Scientists hunt for cholera protection clues to speed up vaccines
NCT ID NCT06455852
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks for immune markers that show whether a person is protected from cholera after vaccination or natural infection. About 1,200 people will receive either a cholera vaccine or a typhoid vaccine (as a comparison) and give blood samples over two years. The goal is to find reliable markers that can speed up the development and approval of new cholera vaccines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLERA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Icddr,B
RECRUITINGDhaka, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One dose, big hope: antibiotic may stop cholera in kids
- Cholera vaccine ring strategy tested in bangladesh hotspots
- Simple handwashing program could curb cholera outbreaks
- New cholera drug could cut antibiotic use and hospital stays
- Cholera vaccine vaxchora put to the test in immune response study
- Soap and sanitation trial aims to slash cholera in congo hotspots